Cell and Gene Therapy Symposium: Challenges of Analyzing ATMPs

July 16th, 2020
8:30am – 11am CST; 2:30pm - 5pm BST
ATMP landing page

Bio-Techne looks forward to welcoming you to this exciting virtual event to discuss the latest topics within the cell & gene therapy community. The theme for this 2nd virtual symposium is a discussion around the “Challenges of analyzing ATMPs”.

Quality control of advanced therapy medicinal products (ATMPs - therapies based on genes, tissues or cells) is complex. Due to the nature of the therapy, there is often only a narrow window of time to determine if a product is safe to provide to a patient. You must also consider challenges while scaling these therapies up when increasing the numbers of patients.

During our 1st virtual symposium we posed a question to our audience of “What are your biggest challenges around quality control?” Key answers included: automation, time, data integrity, robustness, and training – some of which we will be covering during this event.

At Bio-Teche we aim to keep everyone connected, communicating and collaborating to advance the cell and gene therapy research and beyond from bench to clinic. We are looking to bring everyone together to discuss these latest developments and technologies.

We have created an exciting agenda with 6 keynote speakers and a Q&A session.

Join us to find out from leading scientists how they are pushing the boundaries of cell & gene therapy research.


Ben Buer.jpg

Benjamin Buer, Ph.D.
Associate Director of Pharmaceutical Development, Pace Analytical Life Sciences, LLC
“Characterization of Viral-Based Gene Therapies to Ensure Chemical and Physical Stability”

Chris Hege.jpg

Chris Heger, Ph.D.
Senior Manager, Applications Science, Bio-Techne
“Overcoming Analytical Challenges in the Development and Characterization of ATMPs"

Stephen Sullivan.jpg

Stephen Sullivan Ph.D. MBA
Global Alliance for iPSC Therapies
“Quality & Standards for Clinical-Grade Induced Pluripotent Stem Cells”

Steven Keizer.jpg

Steven Keizer
Director, Quality, CCRM

Lindsay Clarke.jpg

Lindsey Clarke, Ph.D.
Head of Cell and Gene Therapy, EMEA, Bio-Techne
Symposium Host


David Smith, MEng, Ph.D.
Director of Research and Development, Hitachi Chemical Advanced Therapeutics Solutions
“CDMO Perspective on the Challenges and Solutions Associated With the Quality Control of Cell Therapy Products”

Moiz Ebrahimjee.jpeg.jpg

Moiz Ebrahimjee
Cell and Gene Therapy Business Development Manager, Synthace Limited
"Computer-Aided Biology: Intelligent Automation for Accelerated Analytics"